MINI FUTURE LONG - APTARGROUP Stock

Certificat

DE000MD4RNR3

Market Closed - Börse Stuttgart 15:56:27 2024-05-17 EDT
5.38 EUR +0.75% Intraday chart for MINI FUTURE LONG - APTARGROUP
Current month+3.26%
1 month+14.96%
Date Price Change
24-05-17 5.38 +0.75%
24-05-16 5.34 -0.37%
24-05-15 5.36 -1.47%
24-05-14 5.44 -0.73%
24-05-13 5.48 -0.90%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 03:56 pm

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellCALL
Underlying APTARGROUP, INC.
Issuer Morgan Stanley
WKN MD4RNR
ISINDE000MD4RNR3
Date issued 2022-05-24
Strike 89.26 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.15
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 5.75
Lowest since issue 1.51

Company Profile

AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
Sector
-
More about the company

Ratings for AptarGroup, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: AptarGroup, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
147.7 USD
Average target price
155 USD
Spread / Average Target
+4.96%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW